Fei Yu | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Fei Yu | Medicine and Dentistry | Best Researcher Award

Prof Fei Yu, Shanghai tenth people’s hospital, China

Prof. Fei Yu, a distinguished expert in Nuclear Medicine, holds a rich educational background with degrees from Soochow University and Fudan University. With a graduation date of June 2012 from Soochow University School of Medicine, he has dedicated himself to advancing the field of Nuclear Medicine through significant contributions and research.

Publication profile

Scopus

Education

Prof. Fei Yu graduated in June 2012 from Soochow University, where he completed his medical education. He previously attended Fudan University from September 1996 to July 2001, earning his degree from the School of Public Health and Community Medicine. Furthering his studies, Prof. Yu obtained his degree from Tongji University’s School of Medicine between March 2005 and March 2008. With a strong foundation in public health and medicine, he has made significant contributions to his field. 🌍📚🏥

Honors and Awards

Prof. Fei Yu is a distinguished researcher recognized for his significant contributions to nuclear medicine. He was awarded the Star of Hope Award by the Chinese Society of Nuclear Medicine in September 2018. His project on targeted therapy for non-small cell lung cancer, supported by the Shanghai Talent Development Fund in September 2017, highlights his innovative approach in the field. He also received the Shanghai Science and Technology Award in November 2010 for developing a 99mTc labeled somatostatin receptor imaging kit for lung cancer diagnosis. Additionally, he was honored with the Huaxia Medical Science and Technology Award and the Hospital Technology Innovation Award for his research on medical ethics and intelligent clinical pathways. 🌟🔬🏆

Research Achievements

Dr. Yang and colleagues have made significant strides in cancer therapy and cardiology. Their 2024 study in Theranostics explores how damaged mitochondrial transfer impacts the bystander effect induced by alpha-particle radiation (🎗️). Another study published in Small reveals that alpha-emitter Radium-223 triggers STING-dependent pyroptosis, enhancing antitumor immunity (💉). Additionally, they developed alpha radionuclide-chelated radioimmunotherapy promoters to advance local radiotherapy strategies, published in Biomaterials Research (📚). In cardiology, their nomogram for predicting major adverse cardiac events in patients with ischemia, featured in Frontiers in Cardiovascular Medicine, is a pivotal contribution (❤️).

Research focus

Prof. Fei Yu is a prominent researcher specializing in nuclear medicine and molecular imaging. His work encompasses the development and evaluation of advanced therapeutic approaches, particularly in the context of neuroendocrine tumors and thyroid cancer. Prof. Yu’s research focuses on innovative treatments like peptide receptor radionuclide therapy and the mechanisms of antitumor immunity, including the role of STING-dependent pyroptosis induced by alpha-emitter Radium-223. His contributions significantly enhance understanding of cancer therapies and their implications for patient prognosis. 🔬💉📈

Memberships and Leadership

Prof. Yu is an active member of several professional societies, holding key positions such as Vice Chairman of the Continuing Education Committee of Nuclear Medicine under the Chinese Nuclear Society. His involvement in these organizations reflects his dedication to the growth and education within the field, emphasizing the importance of collaboration and knowledge sharing.

Funding and Research Projects

Prof. Yu leads multiple funded projects, including the National Natural Science Foundation project on interstitial radiotherapy combined with immunotherapy for non-small cell lung cancer. His work is characterized by a strong focus on innovative therapies that integrate radiological techniques with emerging treatment modalities.

Publication top notes

Triglyceride-glucose index is associated with myocardial ischemia and poor prognosis in patients with ischemia and no obstructive coronary artery disease

The D-SPECT SH reconstruction protocol: improved quantification of small left ventricle volumes

The Effect of Radioiodine Therapy on the Prognosis of Differentiated Thyroid Cancer with Lung Metastases

Extended peptide receptor radionuclide therapy: evaluating nephrotoxicity and therapeutic effectiveness in neuroendocrine tumor patients receiving more than four treatment cycles

Alpha-Emitter Radium-223 Induces STING-Dependent Pyroptosis to Trigger Robust Antitumor Immunity

Conclusion

Prof. Fei Yu exemplifies excellence in nuclear medicine, with a career marked by substantial research contributions, leadership roles, and a commitment to advancing medical science. His innovative approaches to cancer therapy and active involvement in professional societies make him an outstanding candidate for the Best Researcher Award. Prof. Yu’s dedication to improving patient outcomes through research and education sets a high standard for future professionals in the field.

Ashwani Singal | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Ashwani Singal | Medicine  and Dentistry | Best Researcher Award

Prof Ashwani Singal, University of Louisville School of Medicine, United States

Prof. Ashwani Singal, he appears to be a highly suitable candidate for the Best Researcher Award. Here are several reasons supporting this nomination:

Publication Profile

Google Scholar

Research and Academic Excellence

  • Extensive Education: Prof. Singal holds an MBBS, MD in Medicine, and a DM in Gastroenterology, along with postdoctoral training in Transplant Hepatology and Gastroenterology from prestigious institutions like Mayo Clinic and UTMB Galveston.
  • Publications: He has a substantial publication record, including influential papers on liver diseases, alcoholic liver disease, and hepatitis C, demonstrating his contributions to advancing medical knowledge in his field. His work has been recognized in reputable journals and conferences, with multiple posters of distinction presented at AASLD annual conferences.

Clinical Impact

  • Leadership Roles: As the Medical Director of Liver Transplant at the Trager Transplant Institute and a Transplant Hepatologist at Avera Transplant Institute, he plays a critical role in clinical practice and patient care, impacting many lives.
  • Current Support: His involvement in multiple funded research projects indicates ongoing commitment to advancing research in alcohol use disorders and liver diseases, with significant financial backing from NIH and other organizations.

Contributions to Medical Education

  • Teaching and Mentoring: Prof. Singal has extensive experience in teaching medical students and residents across various institutions, having served as a course director and providing numerous lectures and grand rounds. His mentorship has led to several mentees receiving awards for their research.

Professional Engagement

  • Committee Involvement: He has served on numerous committees and councils within professional societies, showcasing his dedication to improving the field of gastroenterology and hepatology.
  • Editorial Roles: Prof. Singal is active in the editorial boards of reputable journals, contributing to the peer-review process and shaping future research directions in his specialty.

Recognition and Awards

  • Recent Nominations: His nomination for the Clinical Innovation Award by the Healio-American College of Gastroenterology and his status as an International Fellow of the National Academy of Medical Science in India highlight his recognition as a leader in his field.

Publication Top Notes

ACG clinical guideline: alcoholic liver disease

The Bioenergetic Health Index: a new concept in mitochondrial translational research

Evolving frequency and outcomes of liver transplantation based on etiology of liver disease

Antioxidants as therapeutic agents for liver disease

Hepatitis C virus and hepatocellular carcinoma: a narrative review

Antiviral therapy reduces risk of hepatocellular carcinoma in patients with hepatitis C virus–related cirrhosis

Mesenteric venous thrombosis

 

Conclusion

Prof. Ashwani Singal’s extensive academic credentials, significant clinical contributions, commitment to education, active engagement in professional societies, and recognition in the form of awards and nominations make him an exemplary candidate for the Best Researcher Award. His work not only contributes to advancing medical knowledge but also directly impacts patient care and the training of future healthcare professionals.

Pedro Antonio Regidor | Medicine and Dentistry | Best Innovation Award

Posted on by ScienceFather

Prof Dr. Pedro Antonio Regidor | Medicine and Dentistry | Best Innovation Award

Prof Dr. Pedro Antonio Regidor, Exeltis, Germany

Born on January 5, 1964, in Madrid, Spain, Prof. Dr. Pedro Antonio Regidor holds dual German and Spanish citizenship. He completed his medical studies at the University of Essen and gained extensive experience in gynecology and obstetrics across Germany and Venezuela. Notably, he served as Medical Director at Exeltis Europe and Global Projects. His qualifications include specialized certifications in radiological diagnostics and gynecological endocrinology. Prof. Dr. Regidor is recognized for his contributions to women’s health and medical innovation. Currently, he continues his work as a Medical Director and private practitioner in Munich, Germany. 🌍💉

Publication profile

Scopus

Professional Background

Prof. Dr. Pedro Antonio Regidor, born on January 5, 1964, in Madrid, Spain, and holding both German and Spanish citizenship, has a distinguished career in the field of gynecology and obstetrics. His educational journey began at the Deutsche Schule Madrid and continued with medical studies at the University of Essen, where he completed his state exams and medical training. His professional experience spans multiple countries and prestigious institutions, including roles as a senior physician and medical director at prominent medical centers in Germany.

Innovative Contributions

Prof. Dr. Regidor has demonstrated a commitment to advancing medical practice and patient care. His roles in various high-profile positions, including Medical Director at Exeltis Europe & Global Projects, reflect his leadership in implementing innovative practices and advancing healthcare delivery. His experience with cutting-edge medical technologies and practices, including his certifications in advanced diagnostic and therapeutic techniques, underscores his contributions to medical innovation.

Awards and Recognitions

Prof. Dr. Regidor’s career is marked by several significant recognitions, including his certifications in specialized fields such as radiological diagnostics and gynecological endocrinology. His role as a Medical Director involved overseeing global projects, indicating a strong track record of managing and implementing innovative solutions across diverse healthcare settings.

Publication Top Notes

  • “The drospirenone only pill as a contraceptive option for breastfeeding women: First data on users’ acceptability and newborn development” (Gynecological Endocrinology, 2024) 📅
  • “OPEN PROSPECTIVE STUDY TO EVALUATE THE EFFICACY OF A NEW VAGINAL PESSARY CONTAINING 300MG TINIDAZOLE, 200MG TIOCONAZOLE AND 100MG LIDOCAINE” (Reproductive Endocrinology, 2024) 📅
  • “Nausea and Vomiting of Pregnancy and its Management with the Dual-Release Formulation of Doxylamine and Pyridoxine” (Geburtshilfe und Frauenheilkunde, 2023) 📅
  • “Improvement in menopausal symptoms with a nutritional product containing evening primrose oil, hop extract, saffron, tryptophan, vitamins B6, D3, K2, B12, and B9” (European Review for Medical and Pharmacological Sciences, 2023) 📅
  • “10-month retrospective study on compliance and tolerability of the drospirenone-only pill” (European Review for Medical and Pharmacological Sciences, 2023) 📅
  • “Miconazole for the treatment of vulvovaginal candidiasis. In vitro, in vivo and clinical results. Review of the literature” (Journal of Obstetrics and Gynaecology, 2023) 📅
  • “Pharmacological and metabolic effects of drospirenone as a progestin-only pill compared to combined formulations with estrogen” (Women’s Health, 2023) 📅
  • “The drospirenone (DRSP)-only pill: clinical implications in the daily use” (European Journal of Contraception and Reproductive Health Care, 2023) 📅
  • “Erratum: Oral Progestins in Hormonal Contraception: Importance and Future Perspectives of a New Progestin Only-Pill Containing 4 mg Drospirenone” (Geburtshilfe und Frauenheilkunde, 2022) 📅
  • “Evaluation of the food effect on a drospirenone only contraceptive containing 4 mg administered with and without high-fat breakfast in a randomised trial” (BMC Women’s Health, 2022) 📅


Conclusion

Prof. Dr. Pedro Antonio Regidor’s extensive experience in gynecology, his leadership in implementing innovative healthcare practices, and his significant contributions to medical advancements, he is a strong candidate for the “Research for Best Innovation Award.” His career reflects a profound impact on medical practices and innovation, aligning well with the award’s criteria.

 

 

 

 

 

 

 

 

Javad Sajedianfard | Dentistry Award | Best Researcher Award

Posted on by ScienceFather

Prof. Javad Sajedianfard | Dentistry Award | Best Researcher Award

Prof. Javad Sajedianfard, Shiraz University, Iran

Prof. Javad Sajedianfard is a dedicated academic and researcher in veterinary medicine and physiology. He completed his DVM at Shiraz University in 1991 and later earned his Ph.D. in physiology from Tarbiat Modarres University in 2003. He holds a permanent veterinary practice license and has participated in various workshops on neuroscience, educational methods, and statistical analysis. Prof. Sajedianfard has held significant academic positions, including Vice Chancellor of the School of Veterinary Medicine at Shiraz University. A member of the Physiology and Pharmacology Society, he also contributes to the editorial board of the Iranian Journal of Medical Sciences.

 

Publication profile

Google Scholar

Education 🎓

Prof. Javad Sajedianfard has a solid educational background in veterinary medicine and physiology. He started his academic journey with a junior certification in English in 1978, followed by completing high school in 1980 at Salman-Parsi High School in Shiraz, Iran. In 1991, he graduated from the Veterinary Medicine School at Shiraz University. Over the years, Prof. Sajedianfard has actively participated in several workshops, including those focused on educational methods, neuroscience physiology, statistical analysis using SPSS, psychological health, and educational administration. His continuous professional development highlights his commitment to education and research in veterinary medicine and related fields.

Professional Certification and Memberships 📜

In 1991, Prof. Sajedianfard obtained a permanent license to practice veterinary medicine in Iran, establishing his credentials in the field. He has also been involved in various professional organizations. He was a member of the Shiraz University Informatics Specialist Committee from 1996 to 1998 and joined the International Brain Research Organization (IBRO) from 2002 to 2004. Since 2007, he has been a member of the Physiology and Pharmacology Society. Additionally, he has served as a member of the Basic Sciences specialist group of the Ministry of Science, Research, and Technology since 2018, and has been on the editorial board of the Iranian Journal of Medical Sciences since 2019. His active participation in these organizations demonstrates his commitment to advancing veterinary medicine and physiology.

Professional Services and Academic Positions 🏛️

Prof. Sajedianfard has extensive teaching and administrative experience. He began teaching pharmacology at Kazeroon Azad Islamic University in 1991 and served as an expert in the Fars Province Veterinary Network from 1992 to 1994. In 1994, he joined the academic staff at the Department of Pharmacology, School of Veterinary Medicine, Shiraz University, where he continued to contribute to academia and research. In 1999, he shifted to the Department of Physiology, where he pursued his Ph.D. in physiology at Tarbiat Modarres University, Tehran, and later became an assistant professor in 2003. He also held administrative roles, including head of the Basic Sciences Department (2003-2005) and vice chancellor of the School of Veterinary Medicine (2005-2007 and 2014-2018). Prof. Sajedianfard’s academic and administrative leadership highlights his dedication to advancing the field of veterinary medicine.

Publication Top Notes 

  • The effects of orally administered Bacillus coagulans and inulin on prevention and progression of rheumatoid arthritis in rats 📊🦠
    Cited by: 98, Year: 2016
  • Effect of adding inulin on microbial and physicochemical properties of low fat probiotic yogurt 🍶🦠
    Cited by: 95, Year: 2011
  • Effect of Probiotic Bacillus Coagulans and Lactobacillus Plantarum on Alleviation of Mercury Toxicity in Rat 🐀💊
    Cited by: 69, Year: 2017
  • Effect of Probiotics Bacillus coagulans and Lactobacillus plantarum on Lipid Profile and Feces Bacteria of Rats Fed Cholesterol-Enriched Diet 🐁🥚
    Cited by: 59, Year: 2019
  • Protective effects of synbiotic diets of Bacillus coagulans, Lactobacillus plantarum and inulin against acute cadmium toxicity in rats 🧪🐀
    Cited by: 55, Year: 2017
  • In vivo measurement of noradrenaline in the locus coeruleus of rats during the formalin test: a microdialysis study 🧠🧬
    Cited by: 49, Year: 2005
  • The effects of probiotic, prebiotic and synbiotic diets containing Bacillus coagulans and inulin on rat intestinal microbiota 🦠🐀
    Cited by: 45, Year: 2015
  • Study of patient’s injuries by stingrays, lethal activity determination and cardiac effects induced by Himantura gerrardi venom 🦈💉
    Cited by: 33, Year: 2009
  • Effects of Camphor on Sexual Behaviors in Male Rats: Effects of camphor on sexual behaviors 🌿🐀
    Cited by: 33, Year: 2006
  • Impact of synbiotic diets including inulin, Bacillus coagulans and Lactobacillus plantarum on intestinal microbiota of rat exposed to cadmium and mercury 🌿🐭
    Cited by: 24, Year: 2015
  • The effect of intra-cerebroventricular injection of insulin on the levels of monoamines on the raphe magnus nucleus of non-diabetic and short-term diabetic rats in the formalin test 💉🧠
    Cited by: 20, Year: 2019
  • The effects of a hydroalcoholic extract of silymarin on serum lipids profiles in streptozotocin-induced diabetic rats 🌿💊
    Cited by: 19, Year: 2014


Conclusion 🏆

Prof. Javad Sajedianfard’s extensive educational background, professional certifications, and active membership in various scientific societies, coupled with his significant academic and administrative roles, make him a strong candidate for the Research for Best Researcher Award. His contributions to veterinary medicine, physiology, and educational leadership demonstrate his dedication to advancing scientific knowledge and training the next generation of professionals. Prof. Sajedianfard’s career reflects a sustained commitment to excellence in research, teaching, and service, positioning him as a suitable nominee for recognition in the field of veterinary and medical sciences.